Royal Bank of Canada’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-115,502
| Closed | -$4.87M | – | 7875 |
|
|
2023
Q2 | $4.87M | Sell |
115,502
-6,528
| -5% | -$264K | ﹤0.01% | 2113 |
|
|
2023
Q1 | $4.35M | Sell |
122,030
-430,745
| -78% | -$15.6M | ﹤0.01% | 2187 |
|
|
2022
Q4 | $20.3M | Buy |
552,775
+507,684
| +1,126% | +$20.1M | 0.01% | 1139 |
|
|
2022
Q3 | $2.13M | Buy |
45,091
+2,081
| +5% | +$134K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $3.08M | Sell |
43,010
-5,455
| -11% | -$399K | ﹤0.01% | 2500 |
|
|
2022
Q1 | $3.92M | Sell |
48,465
-13,005
| -21% | -$1.1M | ﹤0.01% | 2458 |
|
|
2021
Q4 | $6.31M | Buy |
61,470
+6,822
| +12% | +$655K | ﹤0.01% | 2220 |
|
|
2021
Q3 | $4.78M | Buy |
54,648
+2,152
| +4% | +$195K | ﹤0.01% | 2328 |
|
|
2021
Q2 | $4.7M | Buy |
52,496
+5,964
| +13% | +$504K | ﹤0.01% | 2354 |
|
|
2021
Q1 | $3.53M | Sell |
46,532
-104,701
| -69% | -$7.89M | ﹤0.01% | 2520 |
|
|
2020
Q4 | $10.3M | Buy |
151,233
+113,511
| +301% | +$7.08M | ﹤0.01% | 1688 |
|
|
2020
Q3 | $2M | Buy |
37,722
+9
| +0% | +$536 | ﹤0.01% | 2690 |
|
|
2020
Q2 | $2.2M | Buy |
37,713
+25,977
| +221% | +$1.4M | ﹤0.01% | 2538 |
|
|
2020
Q1 | $462K | Sell |
11,736
-5,458
| -32% | -$319K | ﹤0.01% | 3689 |
|
|
2019
Q4 | $1.02M | Sell |
17,194
-75,691
| -81% | -$4.07M | ﹤0.01% | 3430 |
|
|
2019
Q3 | $4.94M | Sell |
92,885
-58,686
| -39% | -$3.01M | ﹤0.01% | 2096 |
|
|
2019
Q2 | $7.75M | Buy |
151,571
+63,557
| +72% | +$2.96M | ﹤0.01% | 1752 |
|
|
2019
Q1 | $4.55M | Buy |
88,014
+69,993
| +388% | +$3.39M | ﹤0.01% | 2084 |
|
|
2018
Q4 | $710K | Sell |
18,021
-20,490
| -53% | -$952K | ﹤0.01% | 3435 |
|
|
2018
Q3 | $1.99M | Buy |
38,511
+18,835
| +96% | +$922K | ﹤0.01% | 2852 |
|
|
2018
Q2 | $923K | Buy |
19,676
+1,232
| +7% | +$51K | ﹤0.01% | 3284 |
|
|
2018
Q1 | $656K | Buy |
18,444
+16,010
| +658% | +$627K | ﹤0.01% | 3502 |
|
|
2017
Q4 | $106K | Sell |
2,434
-7,424
| -75% | -$347K | ﹤0.01% | 4782 |
|
|
2017
Q3 | $516K | Buy |
9,858
+9,213
| +1,428% | +$514K | ﹤0.01% | 3770 |
|
|
2017
Q2 | $37K | Sell |
645
-448,750
| -100% | -$23.3M | ﹤0.01% | 5261 |
|
|
2017
Q1 | $20.6M | Sell |
449,395
-15,772
| -3% | -$785K | 0.01% | 995 |
|
|
2016
Q4 | $24.5M | Buy |
465,167
+158,369
| +52% | +$7.67M | 0.01% | 922 |
|
|
2016
Q3 | $13.7M | Buy |
306,798
+252,490
| +465% | +$11M | 0.01% | 1248 |
|
|
2016
Q2 | $2.07M | Buy |
54,308
+37,571
| +224% | +$1.65M | ﹤0.01% | 2514 |
|
|
2016
Q1 | $690K | Buy |
16,737
+16,716
| +79,600% | +$689K | ﹤0.01% | 3378 |
|
|
2015
Q4 | $1K | Sell |
21
-386
| -95% | -$17.2K | ﹤0.01% | 6513 |
|
|
2015
Q3 | $16K | Buy |
407
+13
| +3% | +$568 | ﹤0.01% | 5664 |
|
|
2015
Q2 | $16K | Buy |
394
+281
| +249% | +$9.7K | ﹤0.01% | 5826 |
|
|
2015
Q1 | $4K | Buy |
+113
| New | +$3.12K | ﹤0.01% | 5807 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Royal Bank of Canada's SYNH Position: Q3 2023 in Review
Royal Bank of Canada sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 115,502 shares — an estimated $4.87M sold.
Royal Bank of Canada first reported a position in SYNH in Q1 2015 and held it in 34 quarters. The position peaked at $24.5M in Q4 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Royal Bank of Canada reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Royal Bank of Canada sold 115,502 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.87M.
- Royal Bank of Canada first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 34 quarters.
- Royal Bank of Canada's Syneos Health, Inc. Class A Common Stock position peaked at $24.5M in Q4 2016.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.